|
|
Volumn 9, Issue 6, 2003, Pages 534-543
|
|
Unmet needs in the treatment of allergic asthma: potential role of novel biologic therapies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
CYTOKINE;
DNA VACCINE;
IMMUNOGLOBULIN E;
MONOCLONAL ANTIBODY;
ASTHMA;
DRUG ANTAGONISM;
ECONOMICS;
EMERGENCY HEALTH SERVICE;
HEALTH CARE DELIVERY;
HEALTH INSURANCE;
HOSPITALIZATION;
HUMAN;
IMMUNOLOGY;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
REVIEW;
STATISTICS;
ANTIBODIES, MONOCLONAL;
ASTHMA;
BIOLOGICAL PRODUCTS;
CYTOKINES;
EMERGENCY SERVICE, HOSPITAL;
HEALTH SERVICES ACCESSIBILITY;
HOSPITALIZATION;
HUMANS;
IMMUNOGLOBULIN E;
MANAGED CARE PROGRAMS;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PRACTICE GUIDELINES;
QUALITY OF LIFE;
VACCINES, DNA;
|
|
EID: 1542437306
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2003.9.6.534 Document Type: Review |
|
Times cited : (8)
|
|
References (86)
|
